AIR Global Files FDA PMTA for Crown Switch Vape Platform
AIIR sits 40% above its 52-week low of $5.29 on light trading volume (0.3× avg).
Summary
AIR Global submitted a PMTA to the FDA for Crown Switch, its rechargeable pod vape built on Greentank's Quantum Vape technology. FDA must first accept the application for review; no timing or outcome is assured.
Key Events · Product Development and Regulatory · AIIR
-
PMTA Submitted for Crown Switch
On 5 November 2026, AIR filed a Premarket Tobacco Product Application with the U.S. FDA for Crown Switch, its next-generation rechargeable pod vape platform.
-
Greentank Technology Underpins Device
Crown Switch runs on Greentank's Quantum Vape chip-based aerosolization system, distinct from coil-and-wick and ceramic heating. In July 2026, AIR invested $20 million in Greentank preferred shares at a pre-money valuation of roughly $170 million, with a warrant to add 20% ownership over 24 months.
-
FDA Acceptance Is the First Hurdle
FDA will first determine whether to accept and file the application for scientific review, and may request additional information or conduct inspections. The final determination rests solely with the FDA.
-
U.S. Strategy Beyond Shisha
The submission extends AIR's U.S. presence beyond its Al Fakher shisha business into regulated nicotine delivery, where the company argues illicit products hold significant share.
Analysis · AIIR · Manufacturing
This is AIR's formal bid to enter the regulated U.S. vaping market, which the company says is largely served today by unauthorized, illicit products. No revenue or cash comes from the filing itself: FDA must first decide whether to accept and file the application, then run a scientific review that can end in authorization or a marketing denial order. That binary outcome is what matters — approval would open a new U.S. nicotine category on top of the Al Fakher shisha business, while a refusal-to-file or denial would strand the Crown Switch platform and the $20M Greentank preferred investment behind it. No timeline or cost estimate for the review is given.
How filings like this one have moved
In the 30 days to Nov 5, 2026, 33.4% of the 2397 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AIIR was trading at $7.41 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $5.29 to $15.30. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.